A Constrained Maximum Likelihood Method for Pleiotropy‐Robust Mendelian Randomization Using Family‐Based GWAS Summary Statistics
Statistics in Medicine · 2026-11 · 45 (25-27)
DOI: 10.1002/sim.70810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 08.11.2026. Verfasst von Jia-Hao Mai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health (State Key Laboratory of Multi-Organ Injury Prevention and Treatment, and Guangdong Provincial K…. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Genome-Wide Association Study, Genetic Pleiotropy. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Hainan Province Science and Technology Special Fund.
Abstract (Originalsprache)
Mendelian randomization (MR) using genome‐wide association study (GWAS) summary statistics is widely used for causal inference. However, conventional MR methods relying on population‐based GWAS are vulnerable to biases arising from family‐level confounders. While family‐based GWAS (FGWAS) designs offer a solution to address these effects, existing MR methodologies are not optimized for the unique structure of FGWAS data, often resulting in reduced statistical power. Therefore, in this paper, we propose the MRcML‐Family (MR based on constrained maximum likelihood for families), a novel method specifically tailored for FGWAS summary statistics. The core innovation of MRcML‐Family lies in its unified framework which simultaneously integrates genetic information from offspring (direct effects) and parents (indirect effects) as instrumental variables. By applying different constraints, the method effectively identifies and corrects for horizontal pleiotropy. Comprehensive simulation studies demonstrate that MRcML‐Family yields nearly unbiased causal estimates and maintains robust Type I error rate control whether or not the instrument strength independent of direct effect assumption holds, even in challenging scenarios with a limited number of SNPs and small FGWAS sample sizes. Furthermore, real‐world data analyses using UK Biobank data show that MRcML‐Family provides causal estimates highly consistent with existing literature and recovers the established “gold standard” relationship between height and body mass index. Additionally, it showed higher statistical power than the compared methods in the evaluated scenarios, mitigating the efficiency loss typically associated with family‐based designs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, School of Public Health (State Key Laboratory of Multi-Organ Injury Prevention and Treatment, and Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical Universi…
ORCID-Profile: Ji-Yuan Zhou
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Hainan Province Science and Technology Special Fund
Zitieren
APA
Mai, J. H., Zhang, S., Zhu, Q. W., Zhou, W. Y., Zhang, Y., Yu, J. D., & Zhou, J. Y. (2026). A Constrained Maximum Likelihood Method for Pleiotropy‐Robust Mendelian Randomization Using Family‐Based GWAS Summary Statistics. Statistics in Medicine, 45(25-27). https://doi.org/10.1002/sim.70810
Vancouver
Mai JH, Zhang S, Zhu QW, Zhou WY, Zhang Y, Yu JD, et al. A Constrained Maximum Likelihood Method for Pleiotropy‐Robust Mendelian Randomization Using Family‐Based GWAS Summary Statistics. Statistics in Medicine. 2026;45(25-27). doi:10.1002/sim.70810
BibTeX
@article{Mai2026,
author = {Mai, Jia-Hao and Zhang, Shun and Zhu, Qiu-Wen and Zhou, Wei-Ying and Zhang, Yang and Yu, Jun-Da and Zhou, Ji-Yuan},
title = {A Constrained Maximum Likelihood Method for Pleiotropy‐Robust Mendelian Randomization Using Family‐Based GWAS Summary Statistics},
journal = {Statistics in Medicine},
year = {2026},
volume = {45},
number = {25-27},
doi = {10.1002/sim.70810}
}
EUVIMED